About this product
Melanotan 10 mg is supplied at 10 mg / 3 ml. [Per-product description to be added.]
What It Does
Six Reasons Clinicians Recommend MT-1 (Afamelanotide)
A synthetic analog of alpha-melanocyte stimulating hormone (α-MSH) that selectively activates the MC1 receptor on melanocytes — stimulating eumelanin production for photoprotection and natural skin darkening. The active compound in FDA-approved Scenesse, the only melanocortin analog with regulatory approval.
Natural Skin Darkening via Eumelanin Stimulation
MT-1 binds selectively to the melanocortin 1 receptor (MC1R) on melanocytes — stimulating the production of eumelanin, the dark pigment responsible for skin tanning and UV photoprotection. Clinical trials demonstrate visible skin darkening in 92% of participants, with mean melanin density increases of 41% over a two-week protocol. The tanning effect peaks approximately one week after treatment completion and is enhanced by UV exposure.
UV Photoprotection
The eumelanin produced in response to MT-1 acts as a natural physical barrier against UV radiation — absorbing and scattering UVA and UVB rays before they can damage DNA in skin cells. Phase 3 clinical trials in EPP patients demonstrated that MT-1 increased pain-free sun exposure time by 70% compared to placebo — from a median of 40.8 hours to 69.4 hours over six months. This photoprotective effect benefits both photosensitive patients and individuals seeking UV damage reduction.
Cleaner Safety Profile Than Melanotan II
MT-1's high selectivity for MC1R is its most important clinical differentiator. Melanotan II (MT-2) is a non-selective pan-melanocortin agonist that activates MC1R, MC3R, MC4R, and MC5R simultaneously — producing significant off-target effects including sexual arousal, appetite suppression, nausea, and cardiovascular changes. MT-1's MC1R selectivity confines its activity to melanogenesis, producing a substantially cleaner side effect profile with no significant cardiovascular, sexual, or appetite-related effects.
Anti-Inflammatory & Acne Reduction
Beyond melanogenesis, MC1R activation has demonstrated anti-inflammatory effects in skin tissue. A Phase 2 clinical trial found that MT-1 administration produced significant reductions in inflammatory acne lesions on the face and trunk, alongside improvements in quality of life scores. MC1R's role in modulating skin inflammation makes MT-1 a compound of interest for inflammatory dermatological conditions beyond its primary photoprotective indication.
Neuroprotective Properties
Research has identified neuroprotective activity associated with MT-1's activity at the melanocortin 4 receptor (MC4R) — a secondary binding target present in the central nervous system. Studies suggest MT-1 may reduce neuroinflammation and support neuronal survival under oxidative stress conditions. While neuroprotection is not its primary indication, these findings add a longevity-relevant dimension to MT-1's broader biological profile.
Vitiligo & Repigmentation Support
MT-1 has been studied as an adjunct to narrowband UVB therapy for vitiligo — a condition characterized by loss of skin pigmentation due to melanocyte destruction. A randomized controlled trial found that afamelanotide combined with NB-UVB produced faster and deeper repigmentation than NB-UVB alone, with patients achieving meaningful repigmentation in a shorter treatment period. This opens a clinical application beyond cosmetic tanning.
MT-1 vs Melanotan II — Why Selectivity Matters
Melanotan II is widely sold online but is illegal for over-the-counter sale, unregulated, and carries documented risks of cardiovascular events, priapism, and nausea due to its non-selective activation of multiple melanocortin receptors. MT-1 achieves comparable tanning results through MC1R-selective activation — the mechanism the body uses naturally — with a clinical safety profile validated through FDA approval of afamelanotide (Scenesse) for EPP. Available with a valid physician consultation only.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Available with a valid physician consultation only. Requires regular dermatological monitoring.
Formulated by Dr. Sasson Moulavi
Every Lavi MD peptide is developed under the direction of Dr. Sasson Moulavi, the physician behind the brand. Formulations are built to clinical specification, not sourced from anonymous suppliers.
Dr. Moulavi earned his Doctor of Medicine from the University of Toronto and completed postgraduate training at McGill University in Montreal. He holds Board Certification in Anti-Aging Medicine and Bariatric Medicine, and is a member of the American Academy of Anti-Aging Medicine and the American Society of Bariatric Physicians. With over three decades of clinical experience in bariatric, family, and anti-aging medicine, he serves as Medical Director and prescribing physician for Lavi MD, overseeing formulation standards and clinical protocols.
Simple, invoice-based ordering
No card is charged on this site. You build a request, we confirm it, and you pay a proper invoice. Built for how clinics and pharmacies actually buy.
Browse & build
Add products to your order request at wholesale pricing. No payment required.
Submit request
Send your request to our team. We review availability and confirm your order.
Get invoiced
You receive a QuickBooks invoice for the confirmed order and pay securely there.
Cold-chain ship
Once paid, your order is fulfilled and shipped cold-chain by our team.
Why Lavi MD
Not All Peptide Brands Are Equal
Most peptide suppliers prioritize volume over patients. We were built differently — by a physician, for patients.
Brands / Suppliers
Medical Director on Staff
Sasson Moulavi, MD
Dispensing Physician · Chayim Therapeutics, LLC
West Palm Beach, FL
"Every product we offer is something I would prescribe to my own patients. Our formulations are designed for clinical outcomes — not marketing claims."
How We Operate
Built by a Physician, Not a Marketing Team
Lavi MD was founded under physician supervision. Every formulation, every dose, every protocol is reviewed by Dr. Moulavi before it reaches a patient — not outsourced to a contract manufacturer with no clinical input.
We Limit Shipping Days to Protect Your Product
We only ship Monday and Tuesday. That's a deliberate decision — it ensures your order arrives before the weekend and never sits in a carrier facility over two days without refrigeration. Most brands don't think that far ahead.
We Treat You Like a Patient, Not an Order Number
Our team includes clinical staff who understand what you're taking and why. If something goes wrong with your order — a warm shipment, a missing component, a question about your protocol — we fix it. No automated runaround.
Proud Members of the
American Peptide Association
The American Peptide Association is the leading industry body advancing the science, safety, and standards of peptide research. Our membership reflects our unwavering commitment to purity, transparency, and responsible sourcing — giving you full confidence in every product you purchase.
